论文部分内容阅读
宫颈鳞癌在印度妇女中最常见,其发病率为20～45/100000人次,其中大多数(80％)为局部晚期病变。最近,有学者在宫颈癌放疗或手术前试行化疗,以期改善局部晚期宫颈癌缓解率和/或生存率。 1990年8月～1992年2月将184例局部晚期宫颈癌(FIGOⅡB～NA期)患者随机分为化疗-放疗(CT-RT)组94例,单纯放疗(RT)组90例。CT-RT组的化疗方案为BIP方案:DDP50mg/m~2,静滴第1天,BLM15mg静推第1天,IFO(异环磷酰胺)lg/m~2,静
Cervical squamous cell carcinoma is the most common among Indian women, with an incidence of 20 to 45/100000 person-times, most of which (80%) are locally advanced. Recently, some scholars have tried chemotherapy for cervical cancer before radiotherapy or surgery in order to improve the remission rate and/or survival rate of locally advanced cervical cancer. From August 1990 to February 1992, 184 patients with locally advanced cervical cancer (FIGOIIB-NA stage) were randomly divided into the chemotherapy-radiotherapy (CT-RT) group of 94 patients and the simple radiotherapy (RT) group of 90 patients. CT-RT group chemotherapy program for the BIP program: DDP50mg/m~2, intravenous infusion on the first day, BLM15mg static on the first day, IFO (ifosfamide) lg/m~2, static